<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39495479</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2509-2723</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>GeroScience</Title><ISOAbbreviation>Geroscience</ISOAbbreviation></Journal><ArticleTitle>Novel biomarkers of mitochondrial dysfunction in Long COVID patients.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s11357-024-01398-4</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) can lead to severe acute respiratory syndrome, and while most individuals recover within weeks, approximately 30-40% experience persistent symptoms collectively known as Long COVID, post-COVID-19 syndrome, or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC). These enduring symptoms, including fatigue, respiratory difficulties, body pain, short-term memory loss, concentration issues, and sleep disturbances, can persist for months. According to recent studies, SARS-CoV-2 infection causes prolonged disruptions in mitochondrial function, significantly altering cellular energy metabolism. Our research employed transmission electron microscopy to reveal distinct mitochondrial structural abnormalities in Long COVID patients, notably including significant swelling, disrupted cristae, and an overall irregular morphology, which collectively indicates severe mitochondrial distress. We noted increased levels of superoxide dismutase 1 which signals oxidative stress and elevated autophagy-related 4B cysteine peptidase levels, indicating disruptions in mitophagy. Importantly, our analysis also identified reduced levels of circulating cell-free mitochondrial DNA (ccf-mtDNA) in these patients, serving as a novel biomarker for the condition. These findings underscore the crucial role of persistent mitochondrial dysfunction in the pathogenesis of Long COVID. Further exploration of the cellular and molecular mechanisms underlying post-viral mitochondrial dysfunction is critical, particularly to understand the roles of autoimmune reactions and the reactivation of latent viruses in perpetuating these conditions. This comprehensive understanding could pave the way for targeted therapeutic interventions designed to alleviate the chronic impacts of Long COVID. By utilizing circulating ccf-mtDNA and other novel mitochondrial biomarkers, we can enhance our diagnostic capabilities and improve the management of this complex syndrome.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sz&#xf6;gi</LastName><ForeName>Titanilla</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borsos</LastName><ForeName>Barbara N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Competence Centre of the Life Sciences Cluster of the Centre of Excellence for Interdisciplinary Research, Development and Innovation, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masic</LastName><ForeName>Dejana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Radics</LastName><ForeName>Bence</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bella</LastName><ForeName>Zsolt</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Oto-Rhino- Laryngology and Head-Neck Surgery, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>B&#xe1;nfi</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Pediatrics and Pediatric Health Center, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xd6;rd&#xf6;g</LastName><ForeName>N&#xf3;ra</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zsiros</LastName><ForeName>Csenge</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Oto-Rhino- Laryngology and Head-Neck Surgery, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kiricsi</LastName><ForeName>&#xc1;gnes</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Department of Oto-Rhino- Laryngology and Head-Neck Surgery, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pankotai-Bod&#xf3;</LastName><ForeName>Gabriella</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kov&#xe1;cs</LastName><ForeName>&#xc1;gnes</ForeName><Initials>&#xc1;</Initials><AffiliationInfo><Affiliation>Pulmonology Clinic, Albert Szent-Gy&#xf6;rgyi Medical and Pharmaceutical Centre, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Par&#xf3;czai</LastName><ForeName>D&#xf3;ra</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Botk&#xe1;n&#xe9;</LastName><ForeName>Andrea Lugosi</ForeName><Initials>AL</Initials><AffiliationInfo><Affiliation>Pulmonology Clinic, Albert Szent-Gy&#xf6;rgyi Medical and Pharmaceutical Centre, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kajt&#xe1;r</LastName><ForeName>B&#xe9;la</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of P&#xe9;cs Medical School, P&#xe9;cs, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xfc;k&#xf6;sd</LastName><ForeName>Farkas</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lehoczki</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Doctoral College, Health Sciences Program, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Preventive Medicine and Public Health, Semmelweis University, Budapest, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Polg&#xe1;r</LastName><ForeName>Tam&#xe1;s</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Biophysics, HUN-REN Biological Research Centre, Szeged, Hungary.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Theoretical Medicine Doctoral School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Letoha</LastName><ForeName>Annam&#xe1;ria</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Pankotai</LastName><ForeName>Tibor</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-9810-5465</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary. pankotai.tibor@szte.hu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Competence Centre of the Life Sciences Cluster of the Centre of Excellence for Interdisciplinary Research, Development and Innovation, University of Szeged, Szeged, Hungary. pankotai.tibor@szte.hu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Genome Integrity and DNA Repair Core Group, Hungarian Centre of Excellence for Molecular Medicine (HCEMM), Hungarian Centre of Excellence for Molecular Medicine, Szeged, Hungary. pankotai.tibor@szte.hu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tiszlavicz</LastName><ForeName>L&#xe1;szl&#xf3;</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pathology, Albert Szent-Gy&#xf6;rgyi Medical School, University of Szeged, Szeged, Hungary.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>NKFI-FK 132080</GrantID><Agency>Nemzeti Kutat&#xe1;si Fejleszt&#xe9;si &#xe9;s Innov&#xe1;ci&#xf3;s Hivatal</Agency><Country/></Grant><Grant><GrantID>RRF-2.3.1-21-2022-00003</GrantID><Agency>Nemzeti Kutat&#xe1;si Fejleszt&#xe9;si &#xe9;s Innov&#xe1;ci&#xf3;s Hivatal</Agency><Country/></Grant><Grant><GrantID>739593</GrantID><Agency>Horizon 2020 Framework Programme</Agency><Country/></Grant><Grant><GrantID>TKP-2021-EGA-05</GrantID><Agency>Nemzeti Kutat&#xe1;si, Fejleszt&#xe9;si &#xe9;s Innovaci&#xf3;s Alap</Agency><Country/></Grant><Grant><GrantID>2022-2.1.1-NL-2022-00005</GrantID><Agency>Nemzeti Kutat&#xe1;si, Fejleszt&#xe9;si &#xe9;s Innovaci&#xf3;s Alap</Agency><Country/></Grant><Grant><GrantID>TKP2021-NKTA-47</GrantID><Agency>Nemzeti Kutat&#xe1;si, Fejleszt&#xe9;si &#xe9;s Innovaci&#xf3;s Alap</Agency><Country/></Grant><Grant><GrantID>POST-COVID2021-36</GrantID><Agency>Magyar Tudom&#xe1;nyos Akad&#xe9;mia</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Geroscience</MedlineTA><NlmUniqueID>101686284</NlmUniqueID><ISSNLinking>2509-2723</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Mitochondria</Keyword><Keyword MajorTopicYN="N">Mitophagy</Keyword><Keyword MajorTopicYN="N">Oxidative damage</Keyword><Keyword MajorTopicYN="N">Post-COVID</Keyword><Keyword MajorTopicYN="N">mtDNA</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>12</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>11</Hour><Minute>22</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39495479</ArticleId><ArticleId IdType="doi">10.1007/s11357-024-01398-4</ArticleId><ArticleId IdType="pii">10.1007/s11357-024-01398-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization. WHO COVID-19 dashboard. https://data.who.int/dashboards/covid19/deaths?n=o . Accessed on 07/08/2024.</Citation></Reference><Reference><Citation>Nikolich-Zugich J, Knox KS, Rios CT, Natt B, Bhattacharya D, Fain MJ. SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience. 2020;42:505&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pubmed">32274617</ArticleId><ArticleId IdType="pmc">7145538</ArticleId><ArticleId IdType="doi">10.1007/s11357-020-00186-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterfi A, Meszaros A, Szarvas Z, Penzes M, Fekete M, Feher A, Lehoczki A, Csipo T, Fazekas-Pongor V. Comorbidities and increased mortality of COVID-19 among the elderly: a systematic review. Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00206 .</Citation></Reference><Reference><Citation>Fekete M, Szarvas Z, Fazekas-Pongor V, Feher A, Dosa N, Lehoczki A, Tarantini S, Varga JT. COVID-19 infection in patients with chronic obstructive pulmonary disease: from pathophysiology to therapy. Mini-review. Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00172 .</Citation></Reference><Reference><Citation>Feher A, Szarvas Z, Lehoczki A, Fekete M, Fazekas-Pongor V. Co-infections in COVID-19 patients and correlation with mortality rate. Minireview. Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00015 .</Citation></Reference><Reference><Citation>Quarleri J, Galvan V, Delpino MV. Omicron variant of the SARS-CoV-2: a quest to define the consequences of its high mutational load. Geroscience. 2022;44:53&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34921354</ArticleId><ArticleId IdType="doi">10.1007/s11357-021-00500-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C, Bhattacharya M, Sharma AR, Dhama K, Lee SS. Continent-wide evolutionary trends of emerging SARS-CoV-2 variants: dynamic profiles from Alpha to Omicron. Geroscience. 2022:1&#x2013;22. https://doi.org/10.1007/s11357-022-00619-y .</Citation></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, Karamchandani U, Simms-Williams N, Cassambai S, Ardavani A, Wilkinson TJ, Hawthorne G, Curtis F, Kingsnorth AP, Almaqhawi A, Ward T, Ayoubkhani D, Banerjee A, Calvert M, Shafran R, Stephenson T, Sterne J, Ward H, Evans RA, Zaccardi F, Wright S, Khunti K. The prevalence and long-term health effects of Long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023;55: 101762.</Citation><ArticleIdList><ArticleId IdType="pubmed">36474804</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition . Accessed at 2024.06.02.</Citation></Reference><Reference><Citation>Bhattacharjee N, Sarkar P, Sarkar T. Beyond the acute illness: exploring Long COVID and its impact on multiple organ systems. Physiol Int. 2023;110:291&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">37943302</ArticleId><ArticleId IdType="doi">10.1556/2060.2023.00256</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje M, Iwasaki A. The neurobiology of Long COVID. Neuron. 2022;110:3484&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pubmed">36288726</ArticleId><ArticleId IdType="pmc">9537254</ArticleId><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansell V, Hall Dykgraaf S, Kidd M, Goodyear-Smith F. Long COVID and older people. Lancet Healthy Longev. 2022;3:e849&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">36480981</ArticleId><ArticleId IdType="doi">10.1016/S2666-7568(22)00245-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gennaro F, Belati A, Tulone O, Diella L, Fiore Bavaro D, Bonica R, Genna V, Smith L, Trott M, Bruyere O, Mirarchi L, Cusumano C, Dominguez LJ, Saracino A, Veronese N, Barbagallo M. Incidence of Long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients. Intern Emerg Med. 2023;18:1573&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">36449260</ArticleId><ArticleId IdType="doi">10.1007/s11739-022-03164-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Julg B, Mohandas S, Bradfute SB, Force RMPT. Viral persistence, reactivation, and mechanisms of Long COVID. Elife. 2023;12. https://doi.org/10.7554/eLife.86015 .</Citation></Reference><Reference><Citation>Saito S, Shahbaz S, Luo X, Osman M, Redmond D, Cohen Tervaert JW, Li L, Elahi S. Metabolomic and immune alterations in Long COVID patients with chronic fatigue syndrome. Front Immunol. 2024;15:1341843.</Citation><ArticleIdList><ArticleId IdType="pubmed">38304426</ArticleId><ArticleId IdType="pmc">10830702</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1341843</ArticleId></ArticleIdList></Reference><Reference><Citation>Elizalde-Diaz JP, Miranda-Narvaez CL, Martinez-Lazcano JC, Martinez-Martinez E. The relationship between chronic immune response and neurodegenerative damage in Long COVID-19. Front Immunol. 2022;13:1039427.</Citation><ArticleIdList><ArticleId IdType="pubmed">36591299</ArticleId><ArticleId IdType="pmc">9800881</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.1039427</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell SJ, Parker K, Lehoczki A, Lieberman D, Partha IS, Scott SJ, Phillips LR, Fain MJ, Nikolich JZ. Post-acute sequelae of SARS-CoV-2 infection (Long COVID) in older adults. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01227-8 .</Citation></Reference><Reference><Citation>Greenhalgh T, Sivan M, Perlowski A, Nikolich JZ. Long COVID: a clinical update. Lancet. 2024. https://doi.org/10.1016/S0140-6736(24)01136-X .</Citation></Reference><Reference><Citation>Chilunga FP, Appelman B, van Vugt M, Kalverda K, Smeele P, van Es J, Wiersinga WJ, Rostila M, Prins M, Stronks K, Norredam M, Agyemang C. Differences in incidence, nature of symptoms, and duration of Long COVID among hospitalised migrant and non-migrant patients in the Netherlands: a retrospective cohort study. Lancet Reg Health Eur. 2023;29:100630.</Citation><ArticleIdList><ArticleId IdType="pubmed">37261215</ArticleId><ArticleId IdType="pmc">10079482</ArticleId><ArticleId IdType="doi">10.1016/j.lanepe.2023.100630</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi C, Osborne T, Bailey R, Cooper A, Hollinghurst JP, Akbari A, Crowder R, Peters H, Law RJ, Lewis R, Smith D, Edwards A, Lyons RA. Impact of COVID-19 pandemic on incidence of long-term conditions in Wales: a population data linkage study using primary and secondary care health records. Br J Gen Pract. 2023;73:e332&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37105743</ArticleId><ArticleId IdType="pmc">9997656</ArticleId><ArticleId IdType="doi">10.3399/BJGP.2022.0353</ArticleId></ArticleIdList></Reference><Reference><Citation>Frallonardo L, Segala FV, Chhaganlal KD, Yelshazly M, Novara R, Cotugno S, Guido G, Papagni R, Colpani A, De Vito A, Barbagallo M, Madeddu G, Babudieri S, Lochoro P, Ictho J, Putoto G, Veronese N, Saracino A, Di Gennaro F. Incidence and burden of Long COVID in Africa: a systematic review and meta-analysis. Sci Rep. 2023;13:21482.</Citation><ArticleIdList><ArticleId IdType="pubmed">38057338</ArticleId><ArticleId IdType="pmc">10700349</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-48258-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta S, Cristillo V, Camera G, Morotti Colleoni C, Pellitteri G, Viti B, Bianchi E, Gipponi S, Grimoldi M, Valente M, Guttmann S, Cotelli MS, Palumbo P, Gelosa G, Meletti S, Schenone C, Ottaviani D, Filippi M, Zini A, Basilico P, Tancredi L, Cortelli P, Braga M, De Giuli V, Servidei S, Paolicelli D, Verde F, Caproni S, Pisani A, Lo Re V, Massacesi L, Roccatagliata DV, Manganotti P, Spitaleri D, Formenti A, Piccoli M, Marino S, Polverino P, Aguglia U, Ornello R, Perego E, Siciliano G, Merlo P, Capobianco M, Pantoni L, Lugaresi A, Angelocola S, De Rosa A, Sessa M, Beghi E, Agostoni EC, Monaco S, Padovani A, Priori A, Silani V, Tedeschi G, Ferrarese C, for Neuro CI. Incidence and long-term functional outcome of neurologic disorders in hospitalized patients with COVID-19 infected with pre-Omicron variants. Neurology. 2023;101:e892&#x2013;903.</Citation><ArticleIdList><ArticleId IdType="pubmed">37414564</ArticleId><ArticleId IdType="pmc">10501088</ArticleId><ArticleId IdType="doi">10.1212/WNL.0000000000207534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai J, Grace A, Espinoza R, Kurian A. Incidence of Long COVID and associated psychosocial characteristics in a large U.S. city. Soc Psychiatry Psychiatr Epidemiol. 2023. https://doi.org/10.1007/s00127-023-02548-3 .</Citation></Reference><Reference><Citation>Sedgley R, Winer-Jones J, Bonafede M. Long COVID incidence in a large US ambulatory electronic health record system. Am J Epidemiol. 2023;192:1350&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37073410</ArticleId><ArticleId IdType="doi">10.1093/aje/kwad095</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobs MM, Evans E, Ellis C. Racial, ethnic, and sex disparities in the incidence and cognitive symptomology of Long COVID-19. J Natl Med Assoc. 2023;115:233&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">36792456</ArticleId></ArticleIdList></Reference><Reference><Citation>Gado K, Kovacs AK, Domjan G, Nagy ZZ, Bednarik GD. COVID-19 and the elderly. Physiol Int. 2022. https://doi.org/10.1556/2060.2022.00203 .</Citation></Reference><Reference><Citation>Egger M, Wimmer C, Stummer S, Reitelbach J, Bergmann J, Muller F, Jahn K. Reduced health-related quality of life, fatigue, anxiety and depression affect COVID-19 patients in the long-term after chronic critical illness. Sci Rep. 2024;14:3016.</Citation><ArticleIdList><ArticleId IdType="pubmed">38321074</ArticleId><ArticleId IdType="pmc">10847136</ArticleId><ArticleId IdType="doi">10.1038/s41598-024-52908-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Laguarta-Val S, Varillas-Delgado D, Lizcano-Alvarez A, Molero-Sanchez A, Melian-Ortiz A, Cano-de-la-Cuerda R, Jimenez-Antona C. Effects of aerobic exercise therapy through nordic walking program in lactate concentrations, fatigue and quality-of-life in patients with long-COVID syndrome: a non-randomized parallel controlled trial. J Clin Med. 2024;13. https://doi.org/10.3390/jcm13041035 .</Citation></Reference><Reference><Citation>Lau B, Wentz E, Ni Z, Yenokyan K, Vergara C, Mehta SH, Duggal P. Physical health and mental fatigue disability associated with Long COVID: baseline results from a US Nationwide Cohort. Am J Med. 2023. https://doi.org/10.1016/j.amjmed.2023.08.009 .</Citation></Reference><Reference><Citation>Lee JS, Choi Y, Joung JY, Son CG. Clinical and laboratory characteristics of fatigue-dominant long-COVID subjects: a cross-sectional study. Am J Med. 2024. https://doi.org/10.1016/j.amjmed.2024.01.025 .</Citation></Reference><Reference><Citation>Molnar T, Varnai R, Schranz D, Zavori L, Peterfi Z, Sipos D, Tokes-Fuzesi M, Illes Z, Buki A, Csecsei P. Severe fatigue and memory impairment are associated with lower serum level of anti-SARS-CoV-2 antibodies in patients with post-COVID symptoms. J Clin Med. 2021;10. https://doi.org/10.3390/jcm10194337 .</Citation></Reference><Reference><Citation>Zhang J, Shu T, Zhu R, Yang F, Zhang B, Lai X. The long-term effect of COVID-19 disease severity on risk of diabetes incidence and the near 1-year follow-up outcomes among postdischarge patients in Wuhan. J Clin Med. 2022;11. https://doi.org/10.3390/jcm11113094 .</Citation></Reference><Reference><Citation>Venkatesan P. NICE guideline on Long COVID. Lancet Respir Med. 2021;9:129.</Citation><ArticleIdList><ArticleId IdType="pubmed">33453162</ArticleId><ArticleId IdType="pmc">7832375</ArticleId><ArticleId IdType="doi">10.1016/S2213-2600(21)00031-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Bello-Chavolla OY, Fermin-Martinez CA, Ramirez-Garcia D, Vargas-Vazquez A, Fernandez-Chirino L, Basile-Alvarez MR, Sanchez-Castro P, Nunez-Luna A, Antonio-Villa NE. Prevalence and determinants of post-acute sequelae after SARS-CoV-2 infection (Long COVID) among adults in Mexico during 2022: a retrospective analysis of nationally representative data. Lancet Reg Health Am. 2024;30:100688.</Citation><ArticleIdList><ArticleId IdType="pubmed">38327277</ArticleId><ArticleId IdType="pmc">10847769</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang YY, Wei AC. Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage. PLoS ONE. 2024;19:e0297664.</Citation><ArticleIdList><ArticleId IdType="pubmed">38295140</ArticleId><ArticleId IdType="pmc">10830027</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0297664</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar T, Lehoczki A, Fekete M, Varnai R, Zavori L, Erdo-Bonyar S, Simon D, Berki T, Csecsei P, Ezer E. Mitochondrial dysfunction in Long COVID: mechanisms, consequences, and potential therapeutic approaches. Geroscience. 2024. https://doi.org/10.1007/s11357-024-01165-5 .</Citation></Reference><Reference><Citation>Srinivasan K, Pandey AK, Livingston A, Venkatesh S. Roles of host mitochondria in the development of COVID-19 pathology: could mitochondria be a potential therapeutic target? Mol Biomed. 2021;2:38.</Citation><ArticleIdList><ArticleId IdType="pubmed">34841263</ArticleId><ArticleId IdType="pmc">8608434</ArticleId><ArticleId IdType="doi">10.1186/s43556-021-00060-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh KK, Chaubey G, Chen JY, Suravajhala P. Decoding SARS-CoV-2 hijacking of host mitochondria in COVID-19 pathogenesis. Am J Physiol Cell Physiol. 2020;319:C258&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">32510973</ArticleId><ArticleId IdType="pmc">7381712</ArticleId><ArticleId IdType="doi">10.1152/ajpcell.00224.2020</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryback R, Eirin A. Mitochondria, a missing link in COVID-19 heart failure and arrest? Front Cardiovasc Med. 2021;8:830024.</Citation><ArticleIdList><ArticleId IdType="pubmed">35111835</ArticleId><ArticleId IdType="doi">10.3389/fcvm.2021.830024</ArticleId></ArticleIdList></Reference><Reference><Citation>Chernyak BV, Popova EN, Zinovkina LA, Lyamzaev KG, Zinovkin RA. Mitochondria as targets for endothelial protection in COVID-19. Front Physiol. 2020;11:606170.</Citation><ArticleIdList><ArticleId IdType="pubmed">33329059</ArticleId><ArticleId IdType="pmc">7710659</ArticleId><ArticleId IdType="doi">10.3389/fphys.2020.606170</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen ZZ, Johnson L, Trahtemberg U, Baker A, Huq S, Dufresne J, Bowden P, Miao M, Ho JA, Hsu CC, Dos Santos CC, Marshall JG. Mitochondria and cytochrome components released into the plasma of severe COVID-19 and ICU acute respiratory distress syndrome patients. Clin Proteomics. 2023;20:17.</Citation><ArticleIdList><ArticleId IdType="pubmed">37031181</ArticleId><ArticleId IdType="pmc">10082440</ArticleId><ArticleId IdType="doi">10.1186/s12014-023-09394-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Bizjak DA, Ohmayer B, Buhl JL, Schneider EM, Walther P, Calzia E, Jerg A, Matits L, Steinacker JM. Functional and morphological differences of muscle mitochondria in chronic fatigue syndrome and post-COVID syndrome. Int J Mol Sci. 2024;25. https://doi.org/10.3390/ijms25031675 .</Citation></Reference><Reference><Citation>Bhowal C, Ghosh S, Ghatak D, De R. Pathophysiological involvement of host mitochondria in SARS-CoV-2 infection that causes COVID-19: a comprehensive evidential insight. Mol Cell Biochem. 2023;478:1325&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">36308668</ArticleId><ArticleId IdType="doi">10.1007/s11010-022-04593-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari H, Taghizadeh-Hesary F. COVID-19 induced liver injury from a new perspective: mitochondria. Mitochondrion. 2023;70:103&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">37054906</ArticleId><ArticleId IdType="pmc">10088285</ArticleId><ArticleId IdType="doi">10.1016/j.mito.2023.04.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Pintos I, Soriano V. Mitochondrial damage as cause of Long COVID. AIDS Rev. 2023;26:145&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">37879634</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossini E, Concina D, Rinaldi C, Russotto S, Garhwal D, Zeppegno P, Gramaglia C, Kul S, Panella M. Association between plasma redox state/mitochondria function and a flu-like syndrome/COVID-19 in the elderly admitted to a long-term care unit. Front Physiol. 2021;12:707587.</Citation><ArticleIdList><ArticleId IdType="pubmed">34975514</ArticleId><ArticleId IdType="pmc">8715756</ArticleId><ArticleId IdType="doi">10.3389/fphys.2021.707587</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang X, Ismail NI, Rahman A, Xu D, Chan RWY, Ong SG, Ong SB. Long COVID-19 and the heart: is cardiac mitochondria the missing link? Antioxid Redox Signal. 2023;38:599&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">36053670</ArticleId><ArticleId IdType="pmc">10025846</ArticleId></ArticleIdList></Reference><Reference><Citation>Noonong K, Chatatikun M, Surinkaew S, Kotepui M, Hossain R, Bunluepuech K, Noothong C, Tedasen A, Klangbud WK, Imai M, Kawakami F, Kubo M, Kitagawa Y, Ichikawa H, Kanekura T, Sukati S, Somsak V, Udomwech L, Ichikawa T, Nissapatorn V, Tangpong J, Indo HP, Majima HJ. Mitochondrial oxidative stress, mitochondrial ROS storms in Long COVID pathogenesis. Front Immunol. 2023;14:1275001.</Citation><ArticleIdList><ArticleId IdType="pubmed">38187378</ArticleId><ArticleId IdType="pmc">10766822</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1275001</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen TH, Chang CJ, Hung PH. Possible pathogenesis and prevention of Long COVID: SARS-CoV-2-induced mitochondrial disorder. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24098034 .</Citation></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary healthcare professionals. Arch Med Res. 2021;52:575&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">33962805</ArticleId><ArticleId IdType="pmc">8093949</ArticleId><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert A, Gal E, Toth E, Szogi T, Hegyi P, Venglovecz V. Role of CFTR in diabetes-induced pancreatic ductal fluid and HCO(3) (-) secretion. J Physiol. 2024;602:1065&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">38389307</ArticleId><ArticleId IdType="doi">10.1113/JP285702</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodi N, Chandrakumar L, Al Doghmi A, Mezei D, Szalai Z, Barta BP, Balazs J, Bagyanszki M. Intestinal region-specific and layer-dependent induction of TNFalpha in rats with Streptozotocin-induced diabetes and after insulin replacement. Cells. 2021;10. https://doi.org/10.3390/cells10092410 .</Citation></Reference><Reference><Citation>Seligman MEP. Flourish : a visionary new understanding of happiness and well-being. 1st Free Press hardcover ed. New York: Free Press; 2011.</Citation></Reference><Reference><Citation>Metsalu T, Vilo J. ClustVis: a web tool for visualizing clustering of multivariate data using principal component analysis and heatmap. Nucleic Acids Res. 2015;43:W566&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">25969447</ArticleId><ArticleId IdType="pmc">4489295</ArticleId><ArticleId IdType="doi">10.1093/nar/gkv468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishihara N, Eura Y, Mihara K. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity. J Cell Sci. 2004;117:6535&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">15572413</ArticleId><ArticleId IdType="doi">10.1242/jcs.01565</ArticleId></ArticleIdList></Reference><Reference><Citation>Zerihun M, Sukumaran S, Qvit N. The Drp1-mediated mitochondrial fission protein interactome as an emerging core player in mitochondrial dynamics and cardiovascular disease therapy. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24065785 .</Citation></Reference><Reference><Citation>Friedman JR, Nunnari J. Mitochondrial form and function. Nature. 2014;505:335&#x2013;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">24429632</ArticleId><ArticleId IdType="pmc">4075653</ArticleId><ArticleId IdType="doi">10.1038/nature12985</ArticleId></ArticleIdList></Reference><Reference><Citation>Streng L, de Wijs CJ, Raat NJH, Specht PAC, Sneiders D, van der Kaaij M, Endeman H, Mik EG, Harms FA. In vivo and ex vivo mitochondrial function in COVID-19 patients on the intensive care unit. Biomedicines. 2022;10. https://doi.org/10.3390/biomedicines10071746 .</Citation></Reference><Reference><Citation>Silva BSA, Pereira T, Minuzzi LG, Padilha CS, Figueiredo C, Olean-Oliveira T, Dos Santos IVM, von Ah Morano AE, Marchioto Junior O, Ribeiro JPJ, Dos Santos VR, Seelaender M, Teixeira AA, Dos Santos RVT, Lemos VA, Freire A, Dorneles GP, Marmett B, Olean-Oliveira A, Teixeira MFS, Seraphim PM, Caseiro A, Pinho RA, Islam H, Little JP, Kruger K, Rosa-Neto JC, Coelho ESMJ, Lira FS. Mild to moderate post-COVID-19 alters markers of lymphocyte activation, exhaustion, and immunometabolic responses that can be partially associated by physical activity level- an observational sub-analysis fit- COVID study. Front Immunol. 2023;14:1212745.</Citation><ArticleIdList><ArticleId IdType="pubmed">37753077</ArticleId><ArticleId IdType="pmc">10518618</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1212745</ArticleId></ArticleIdList></Reference><Reference><Citation>Peppercorn K, Edgar CD, Kleffmann T, Tate WP. A pilot study on the immune cell proteome of Long COVID patients shows changes to physiological pathways similar to those in myalgic encephalomyelitis/chronic fatigue syndrome. Sci Rep. 2023;13:22068.</Citation><ArticleIdList><ArticleId IdType="pubmed">38086949</ArticleId><ArticleId IdType="pmc">10716514</ArticleId><ArticleId IdType="doi">10.1038/s41598-023-49402-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikesjo F, Sayyab S, Karlsson L, Apostolou E, Rosen A, Hedman K, Lerm M. Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells. Clin Epigenetics. 2022;14:172.</Citation><ArticleIdList><ArticleId IdType="pubmed">36517875</ArticleId><ArticleId IdType="pmc">9748378</ArticleId><ArticleId IdType="doi">10.1186/s13148-022-01398-1</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vitis C, Capalbo C, Torsello A, Napoli C, Salvati V, Loffredo C, Blandino G, Piaggio G, Auciello FR, Pelliccia F, Salerno G, Simmaco M, Di Magno L, Canettieri G, Coluzzi F, Mancini R, Rocco M, Sciacchitano S. Opposite effect of thyroid hormones on oxidative stress and on mitochondrial respiration in COVID-19 patients. Antioxidants (Basel). 2022;11. https://doi.org/10.3390/antiox11101998 .</Citation></Reference><Reference><Citation>Ernst T, Ryan MC, Liang HJ, Wang JP, Cunningham E, Saleh MG, Kottilil S, Chang L. Neuronal and glial metabolite abnormalities in participants with persistent neuropsychiatric symptoms after COVID-19: a brain proton magnetic resonance spectroscopy study. J Infect Dis. 2023;228:1559&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">37540098</ArticleId><ArticleId IdType="pmc">10681871</ArticleId><ArticleId IdType="doi">10.1093/infdis/jiad309</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranisavljev M, Todorovic N, Ostojic J, Ostojic SM. Reduced tissue creatine levels in patients with Long COVID-19: a cross-sectional study. J Postgrad Med. 2023;69:162&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">37171415</ArticleId><ArticleId IdType="pmc">10394531</ArticleId><ArticleId IdType="doi">10.4103/jpgm.jpgm_65_23</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, Loo RL, Begum S, Boughton B, Yang R, Morillon AC, Chin ST, Hall D, Ryan M, Bong SH, Gay M, Edgar DW, Lindon JC, Richards T, Yeap BB, Pettersson S, Spraul M, Schaefer H, Lawler NG, Gray N, Whiley L, Nicholson JK. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. 2021;20:3315&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">34009992</ArticleId><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId></ArticleIdList></Reference><Reference><Citation>Finnigan LEM, Cassar MP, Koziel MJ, Pradines J, Lamlum H, Azer K, Kirby D, Montgomery H, Neubauer S, Valkovic L, Raman B. Efficacy and tolerability of an endogenous metabolic modulator (AXA1125) in fatigue-predominant Long COVID: a single-centre, double-blind, randomised controlled phase 2a pilot study. EClinicalMedicine. 2023;59:101946.</Citation><ArticleIdList><ArticleId IdType="pubmed">37223439</ArticleId><ArticleId IdType="pmc">10102537</ArticleId><ArticleId IdType="doi">10.1016/j.eclinm.2023.101946</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamieson A, Al Saikhan L, Alghamdi L, Hamill Howes L, Purcell H, Hillman T, Heightman M, Treibel T, Orini M, Bell R, Scully M, Hamer M, Chaturvedi N, Montgomery H, Hughes AD, Astin R, Jones S. Mechanisms underlying exercise intolerance in Long COVID: an accumulation of multisystem dysfunction. Physiol Rep. 2024;12:e15940.</Citation><ArticleIdList><ArticleId IdType="pubmed">38346773</ArticleId><ArticleId IdType="pmc">10861355</ArticleId><ArticleId IdType="doi">10.14814/phy2.15940</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim A, Muhammad T, Iqbal MS, Qaisar R. Elevated plasma CAF22 are incompletely restored six months after COVID-19 infection in older men. Exp Gerontol. 2023;171:112034.</Citation><ArticleIdList><ArticleId IdType="pubmed">36423404</ArticleId><ArticleId IdType="doi">10.1016/j.exger.2022.112034</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikuteit M, Baskal S, Klawitter S, Dopfer-Jablonka A, Behrens GMN, Muller F, Schroder D, Klawonn F, Steffens S, Tsikas D. Amino acids, post-translational modifications, nitric oxide, and oxidative stress in serum and urine of Long COVID and ex COVID human subjects. Amino Acids. 2023;55:1173&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">37516715</ArticleId><ArticleId IdType="pmc">10564820</ArticleId><ArticleId IdType="doi">10.1007/s00726-023-03305-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Vollbracht C, Kraft K. Oxidative stress and hyper-inflammation as major drivers of severe COVID-19 and Long COVID: implications for the benefit of high-dose intravenous vitamin C. Front Pharmacol. 2022;13:899198.</Citation><ArticleIdList><ArticleId IdType="pubmed">35571085</ArticleId><ArticleId IdType="pmc">9100929</ArticleId><ArticleId IdType="doi">10.3389/fphar.2022.899198</ArticleId></ArticleIdList></Reference><Reference><Citation>Trimarco V, Izzo R, Mone P, Trimarco B, Santulli G. Targeting endothelial dysfunction and oxidative stress in long-COVID. Pharmacol Res. 2022;184:106451.</Citation><ArticleIdList><ArticleId IdType="pubmed">36108875</ArticleId><ArticleId IdType="pmc">9467917</ArticleId><ArticleId IdType="doi">10.1016/j.phrs.2022.106451</ArticleId></ArticleIdList></Reference><Reference><Citation>Mrakic-Sposta S, Vezzoli A, Garetto G, Paganini M, Camporesi E, Giacon TA, Dellanoce C, Agrimi J, Bosco G. Hyperbaric oxygen therapy counters oxidative stress/inflammation-driven symptoms in Long COVID-19 patients: preliminary outcomes. Metabolites. 2023;13. https://doi.org/10.3390/metabo13101032 .</Citation></Reference><Reference><Citation>Juh&#xe1;sz P, Bohus P, Sipos A, Curtin N, M&#xe9;hes G, Bai P. Oxidative stress and PARP activation in the lungs is an early event in COVID-19 pneumonia. medRxiv. 2024:2024.09.03.24312996.</Citation></Reference><Reference><Citation>Mehrzadi S, Karimi MY, Fatemi A, Reiter RJ, Hosseinzadeh A. SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin. Pharmacol Ther. 2021;224:107825.</Citation><ArticleIdList><ArticleId IdType="pubmed">33662449</ArticleId><ArticleId IdType="pmc">7919585</ArticleId><ArticleId IdType="doi">10.1016/j.pharmthera.2021.107825</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M, Syed GH, Kim SJ, Siddiqui A. Mitochondrial dynamics and viral infections: a close nexus. Biochim Biophys Acta. 2015;1853:2822&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">25595529</ArticleId><ArticleId IdType="pmc">4500740</ArticleId><ArticleId IdType="doi">10.1016/j.bbamcr.2014.12.040</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdes-Aguayo JJ, Garza-Veloz I, Vargas-Rodriguez JR, Martinez-Vazquez MC, Avila-Carrasco L, Bernal-Silva S, Gonzalez-Fuentes C, Comas-Garcia A, Alvarado-Hernandez DE, Centeno-Ramirez ASH, Rodriguez-Sanchez IP, Delgado-Enciso I, Martinez-Fierro ML. Peripheral blood mitochondrial DNA Levels were modulated by SARS-CoV-2 infection severity and its lessening was associated with mortality among hospitalized patients with COVID-19. Front Cell Infect Microbiol. 2021;11:754708.</Citation><ArticleIdList><ArticleId IdType="pubmed">34976854</ArticleId><ArticleId IdType="pmc">8716733</ArticleId><ArticleId IdType="doi">10.3389/fcimb.2021.754708</ArticleId></ArticleIdList></Reference><Reference><Citation>Scozzi D, Cano M, Ma L, Zhou D, Zhu JH, O'Halloran JA, Goss C, Rauseo AM, Liu Z, Sahu SK, Peritore V, Rocco M, Ricci A, Amodeo R, Aimati L, Ibrahim M, Hachem R, Kreisel D, Mudd PA, Kulkarni HS, Gelman AE. Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19. JCI Insight. 2021;6. https://doi.org/10.1172/jci.insight.143299 .</Citation></Reference><Reference><Citation>Valdes-Aguayo JJ, Garza-Veloz I, Badillo-Almaraz JI, Bernal-Silva S, Martinez-Vazquez MC, Juarez-Alcala V, Vargas-Rodriguez JR, Gaeta-Velasco ML, Gonzalez-Fuentes C, Avila-Carrasco L, Martinez-Fierro ML. Mitochondria and mitochondrial DNA: key elements in the pathogenesis and exacerbation of the inflammatory state caused by COVID-19. Medicina (Kaunas). 2021;57. https://doi.org/10.3390/medicina57090928 .</Citation></Reference><Reference><Citation>Archer SL, Dasgupta A, Chen KH, Wu D, Baid K, Mamatis JE, Gonzalez V, Read A, Bentley RE, Martin AY, Mewburn JD, Dunham-Snary KJ, Evans GA, Levy G, Jones O, Al-Qazazi R, Ring B, Alizadeh E, Hindmarch CC, Rossi J, Lima PD, Falzarano D, Banerjee A, Colpitts CC. SARS-CoV-2 mitochondriopathy in COVID-19 pneumonia exacerbates hypoxemia. Redox Biol. 2022;58:102508.</Citation><ArticleIdList><ArticleId IdType="pubmed">36334378</ArticleId><ArticleId IdType="pmc">9558649</ArticleId><ArticleId IdType="doi">10.1016/j.redox.2022.102508</ArticleId></ArticleIdList></Reference><Reference><Citation>Nailwal H, Chan FK. Necroptosis in anti-viral inflammation. Cell Death Differ. 2019;26:4&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">30050058</ArticleId><ArticleId IdType="doi">10.1038/s41418-018-0172-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464:104&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20203610</ArticleId><ArticleId IdType="pmc">2843437</ArticleId><ArticleId IdType="doi">10.1038/nature08780</ArticleId></ArticleIdList></Reference><Reference><Citation>Tilokani L, Nagashima S, Paupe V, Prudent J. Mitochondrial dynamics: overview of molecular mechanisms. Essays Biochem. 2018;62:341&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">30030364</ArticleId><ArticleId IdType="pmc">6056715</ArticleId><ArticleId IdType="doi">10.1042/EBC20170104</ArticleId></ArticleIdList></Reference><Reference><Citation>Siekacz K, Kumor-Kisielewska A, Milkowska-Dymanowska J, Pietrusinska M, Bartczak K, Majewski S, Stanczyk A, Piotrowski WJ, Bialas AJ. Oxidative biomarkers associated with the pulmonary manifestation of post-COVID-19 complications. J Clin Med. 2023;12. https://doi.org/10.3390/jcm12134253 .</Citation></Reference><Reference><Citation>Versace V, Tankisi H. Long-COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): potential neurophysiological biomarkers for these enigmatic entities. Clin Neurophysiol. 2023;147:58&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">36657309</ArticleId><ArticleId IdType="pmc">9838078</ArticleId><ArticleId IdType="doi">10.1016/j.clinph.2023.01.001</ArticleId></ArticleIdList></Reference><Reference><Citation>Tziastoudi M, Cholevas C, Stefanidis I, Theoharides TC. Genetics of COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review. Ann Clin Transl Neurol. 2022;9:1838&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pubmed">36204816</ArticleId><ArticleId IdType="pmc">9639636</ArticleId><ArticleId IdType="doi">10.1002/acn3.51631</ArticleId></ArticleIdList></Reference><Reference><Citation>McLaughlin M, Sanal-Hayes NEM, Hayes LD, Berry EC, Sculthorpe NF. People with Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome exhibit similarly impaired vascular function. Am J Med. 2023.&#xa0; https://doi.org/10.1016/j.amjmed.2023.09.013 .</Citation></Reference><Reference><Citation>Bonilla H, Quach TC, Tiwari A, Bonilla AE, Miglis M, Yang PC, Eggert LE, Sharifi H, Horomanski A, Subramanian A, Smirnoff L, Simpson N, Halawi H, Sum-Ping O, Kalinowski A, Patel ZM, Shafer RW, Geng LN. Myalgic encephalomyelitis/chronic fatigue syndrome is common in post-acute sequelae of SARS-CoV-2 infection (PASC): results from a post-COVID-19 multidisciplinary clinic. Front Neurol. 2023;14:1090747.</Citation><ArticleIdList><ArticleId IdType="pubmed">36908615</ArticleId><ArticleId IdType="pmc">9998690</ArticleId><ArticleId IdType="doi">10.3389/fneur.2023.1090747</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Filgueiras IS, Kedor C, Freitag H, Wittke K, Bauer S, Sepulveda N, Mathias da Fonseca DL, Baiocchi GC, Marques AHC, Kim M, Lange T, Placa DR, Luebber F, Paulus FM, De Vito R, Jurisica I, Schulze-Forster K, Paul F, Bellmann-Strobl J, Rust R, Hoppmann U, Shoenfeld Y, Riemekasten G, Heidecke H, Cabral-Marques O, Scheibenbogen C. Dysregulated autoantibodies targeting vaso- and immunoregulatory receptors in post COVID syndrome correlate with symptom severity. Front Immunol. 2022;13:981532.</Citation><ArticleIdList><ArticleId IdType="pubmed">36238301</ArticleId><ArticleId IdType="pmc">9552223</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2022.981532</ArticleId></ArticleIdList></Reference><Reference><Citation>Fagyas M, Nagy B, Jr., Raduly AP, Manyine IS, Martha L, Erdosi G, Sipka S, Jr., Enyedi E, Szabo AA, Polik Z, Kappelmayer J, Papp Z, Borbely A, Szabo T, Balla J, Balla G, Bai P, Bacsi A, Toth A. The majority of severe COVID-19 patients develop anti-cardiac autoantibodies. Geroscience. 2022:1&#x2013;14. https://doi.org/10.1007/s11357-022-00649-6 .</Citation></Reference><Reference><Citation>Seibert FS, Stervbo U, Wiemers L, Skrzypczyk S, Hogeweg M, Bertram S, Kurek J, Anft M, Westhoff TH, Babel N. Severity of neurological long-COVID symptoms correlates with increased level of autoantibodies targeting vasoregulatory and autonomic nervous system receptors. Autoimmun Rev. 2023;22:103445.</Citation><ArticleIdList><ArticleId IdType="pubmed">37689093</ArticleId><ArticleId IdType="doi">10.1016/j.autrev.2023.103445</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Amiri M, Nilsson AC, Wamberg C, Jensen VVS, Petersen CB, Hejl AM, Lebech AM, Theut AM, Jorgensen CS, Blaabjerg M, Benros ME, Kondziella D. SARS-CoV-2 and autoantibodies in the cerebrospinal fluid of COVID-19 patients: prospective multicentre cohort study. Brain Commun. 2023;5:fcad274.</Citation><ArticleIdList><ArticleId IdType="pubmed">37908236</ArticleId><ArticleId IdType="pmc">10613856</ArticleId><ArticleId IdType="doi">10.1093/braincomms/fcad274</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Yoon T, Ha JW, Kim J, Lee KH, Lee JA, Kim CH, Lee SW, Kim JH, Ahn JY, Ku NS, Choi JY, Yeom JS, Jeong SJ. Prevalence, clinical significance, and persistence of autoantibodies in COVID-19. Virol J. 2023;20:236.</Citation><ArticleIdList><ArticleId IdType="pubmed">37845706</ArticleId><ArticleId IdType="pmc">10577963</ArticleId><ArticleId IdType="doi">10.1186/s12985-023-02191-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Fonseca DLM, Filgueiras IS, Marques AHC, Vojdani E, Halpert G, Ostrinski Y, Baiocchi GC, Placa DR, Freire PP, Pour SZ, Moll G, Catar R, Lavi YB, Silverberg JI, Zimmerman J, Cabral-Miranda G, Carvalho RF, Khan TA, Heidecke H, Dalmolin RJS, Luchessi AD, Ochs HD, Schimke LF, Amital H, Riemekasten G, Zyskind I, Rosenberg AZ, Vojdani A, Shoenfeld Y, Cabral-Marques O. Severe COVID-19 patients exhibit elevated levels of autoantibodies targeting cardiolipin and platelet glycoprotein with age: a systems biology approach. NPJ Aging. 2023;9:21.</Citation><ArticleIdList><ArticleId IdType="pubmed">37620330</ArticleId><ArticleId IdType="pmc">10449916</ArticleId><ArticleId IdType="doi">10.1038/s41514-023-00118-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Credle JJ, Gunn J, Sangkhapreecha P, Monaco DR, Zheng XA, Tsai HJ, Wilbon A, Morgenlander WR, Rastegar A, Dong Y, Jayaraman S, Tosi L, Parekkadan B, Baer AN, Roederer M, Bloch EM, Tobian AAR, Zyskind I, Silverberg JI, Rosenberg AZ, Cox AL, Lloyd T, Mammen AL, Benjamin LH. Unbiased discovery of autoantibodies associated with severe COVID-19 via genome-scale self-assembled DNA-barcoded protein libraries. Nat Biomed Eng. 2022;6:992&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">35986181</ArticleId><ArticleId IdType="pmc">10034860</ArticleId><ArticleId IdType="doi">10.1038/s41551-022-00925-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Casciola-Rosen L, Thiemann DR, Andrade F, Trejo-Zambrano MI, Leonard EK, Spangler JB, Skinner NE, Bailey J, Yegnasubramanian S, Wang R, Vaghasia AM, Gupta A, Cox AL, Ray SC, Linville RM, Guo Z, Searson PC, Machamer CE, Desiderio S, Sauer LM, Laeyendecker O, Garibaldi BT, Gao L, Damarla M, Hassoun PM, Hooper JE, Mecoli CA, Christopher-Stine L, Gutierrez-Alamillo L, Yang Q, Hines D, Clarke WA, Rothman RE, Pekosz A, Fenstermacher KZ, Wang Z, Zeger SL, Rosen A. IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function. JCI Insight. 2022;7. https://doi.org/10.1172/jci.insight.158362 .</Citation></Reference><Reference><Citation>Cabral-Marques O, Halpert G, Schimke LF, Ostrinski Y, Vojdani A, Baiocchi GC, Freire PP, Filgueiras IS, Zyskind I, Lattin MT, Tran F, Schreiber S, Marques AHC, Placa DR, Fonseca DLM, Humrich JY, Muller A, Giil LM, Grasshoff H, Schumann A, Hackel A, Junker J, Meyer C, Ochs HD, Lavi YB, Scheibenbogen C, Dechend R, Jurisica I, Schulze-Forster K, Silverberg JI, Amital H, Zimmerman J, Heidecke H, Rosenberg AZ, Riemekasten G, Shoenfeld Y. Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nat Commun. 2022;13:1220.</Citation><ArticleIdList><ArticleId IdType="pubmed">35264564</ArticleId><ArticleId IdType="pmc">8907309</ArticleId><ArticleId IdType="doi">10.1038/s41467-022-28905-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Florio DN, Beetler DJ, McCabe EJ, Sin J, Ikezu T, Fairweather D. Mitochondrial extracellular vesicles, autoimmunity and myocarditis. Front Immunol. 2024;15:1374796.</Citation><ArticleIdList><ArticleId IdType="pubmed">38550582</ArticleId><ArticleId IdType="pmc">10972887</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1374796</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenegro YHA, Bobermin LD, Sesterheim P, Salvato RS, Anschau F, de Oliveira MJS, Wyse ATS, Netto CA, Goncalves CS, Quincozes-Santos A, Leipnitz G. Serum of COVID-19 patients changes neuroinflammation and mitochondrial homeostasis markers in hippocampus of aged rats. J Neurovirol. 2023;29:577&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pubmed">37501054</ArticleId><ArticleId IdType="doi">10.1007/s13365-023-01156-w</ArticleId></ArticleIdList></Reference><Reference><Citation>Vojdani A, Almulla AF, Zhou B, Al-Hakeim HK, Maes M. Reactivation of herpesvirus type 6 and IgA/IgM-mediated responses to activin-A underpin Long COVID, including affective symptoms and chronic fatigue syndrome. Acta Neuropsychiatr. 2024;36:172&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">38571295</ArticleId><ArticleId IdType="doi">10.1017/neu.2024.10</ArticleId></ArticleIdList></Reference><Reference><Citation>Tassaneeyasin T, Sungkanuparph S, Srichatrapimuk S, Charoensri A, Thammavaranucupt K, Jayanama K, Kirdlarp S. Prevalence and risk factors of cytomegalovirus reactivation in critically Ill patients with COVID-19 pneumonia. PLoS ONE. 2024;19:e0303995.</Citation><ArticleIdList><ArticleId IdType="pubmed">38771836</ArticleId><ArticleId IdType="pmc">11108163</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0303995</ArticleId></ArticleIdList></Reference><Reference><Citation>Talukder S, Deb P, Parveen M, Zannat KE, Bhuiyan AH, Yeasmin M, Molla MMA, Saif-Ur-Rahman KM. Clinical features and outcomes of COVID-19 patients with concomitant herpesvirus co-infection or reactivation: a systematic review. New Microbes New Infect. 2024;58:101233.</Citation><ArticleIdList><ArticleId IdType="pubmed">38425457</ArticleId><ArticleId IdType="pmc">10901905</ArticleId><ArticleId IdType="doi">10.1016/j.nmni.2024.101233</ArticleId></ArticleIdList></Reference><Reference><Citation>Payen SH, Adhikari K, Petereit J, Uppal T, Rossetto CC, Verma SC. SARS-CoV-2 superinfection in CD14(+) monocytes with latent human cytomegalovirus (HCMV) promotes inflammatory cascade. Virus Res. 2024;345:199375.</Citation><ArticleIdList><ArticleId IdType="pubmed">38642618</ArticleId><ArticleId IdType="pmc">11061749</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2024.199375</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattei A, Schiavoni L, Riva E, Ciccozzi M, Veralli R, Urselli A, Citriniti V, Nenna A, Pascarella G, Costa F, Cataldo R, Agro FE, Carassiti M. Epstein-Barr virus, cytomegalovirus, and herpes simplex-1/2 reactivations in critically ill patients with COVID-19. Intensive Care Med Exp. 2024;12:40.</Citation><ArticleIdList><ArticleId IdType="pubmed">38649512</ArticleId><ArticleId IdType="pmc">11035506</ArticleId><ArticleId IdType="doi">10.1186/s40635-024-00624-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Grubelnik G, Korva M, Kogoj R, Polanc T, Mavric M, Jevsnik Virant M, Ursic T, Kese D, Seme K, Petrovec M, Jereb M, Avsic-Zupanc T. Herpesviridae and atypical bacteria co-detections in lower respiratory tract samples of SARS-CoV-2-positive patients admitted to an intensive care unit. Microorganisms. 2024;12. https://doi.org/10.3390/microorganisms12040714 .</Citation></Reference><Reference><Citation>Haddad M, Sheybani F, Olfati N, Nahayati MA, Boostani R, Layegh P, Rashid-Nejad A. Central nervous system reactivation of herpesviridae family in patients with COVID-19. J Neurovirol. 2023;29:211&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37097596</ArticleId><ArticleId IdType="pmc">10127951</ArticleId><ArticleId IdType="doi">10.1007/s13365-023-01132-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacconi R, Cardelli M, Piacenza F, Pierpaoli E, Farnocchia E, Di Rosa M, Bonfigli AR, Casoli T, Marchegiani F, Marcheselli F, Recchioni R, Stripoli P, Galeazzi R, Cherubini A, Fedecostante M, Sarzani R, Di Pentima C, Giordano P, Antonicelli R, Provinciali M, Lattanzio F. Effect of cytomegalovirus reactivation on inflammatory status and mortality of older COVID-19 patients. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms24076832 .</Citation></Reference><Reference><Citation>Bernal KDE, Whitehurst CB. Incidence of Epstein-Barr virus reactivation is elevated in COVID-19 patients. Virus Res. 2023;334:199157.</Citation><ArticleIdList><ArticleId IdType="pubmed">37364815</ArticleId><ArticleId IdType="pmc">10292739</ArticleId><ArticleId IdType="doi">10.1016/j.virusres.2023.199157</ArticleId></ArticleIdList></Reference><Reference><Citation>Banko A, Miljanovic D, Cirkovic A. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: old players on the new field. Int J Infect Dis. 2023;130:108&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">36736577</ArticleId><ArticleId IdType="pmc">9889115</ArticleId><ArticleId IdType="doi">10.1016/j.ijid.2023.01.036</ArticleId></ArticleIdList></Reference><Reference><Citation>Reizine F, Liard C, Pronier C, Thibault V, Maamar A, Gacouin A, Tadie JM. Herpesviridae systemic reactivation in patients with COVID-19-associated ARDS. J Hosp Infect. 2022;119:189&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">34800612</ArticleId><ArticleId IdType="doi">10.1016/j.jhin.2021.11.007</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino K, Alves LS, Raposo JV, Medeiros T, Souza CF, Silva AAD, de Paula VS, Almeida JR. Presence and clinical impact of human herpesvirus-6 infection in patients with moderate to critical coronavirus disease-19. J Med Virol. 2022;94:1212&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">34647632</ArticleId><ArticleId IdType="doi">10.1002/jmv.27392</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J, Song J, Dai L, Post SR, Qin Z. SARS-CoV-2 infection and lytic reactivation of herpesviruses: a potential threat in the postpandemic era? J Med Virol. 2022;94:5103&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">35819034</ArticleId><ArticleId IdType="pmc">9350099</ArticleId><ArticleId IdType="doi">10.1002/jmv.27994</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks B, Tancredi C, Song Y, Mogus AT, Huang MW, Zhu H, Phan TL, Zhu H, Kadl A, Woodfolk J, Jerome KR, Zeichner SL. Epstein-Barr virus and human herpesvirus-6 reactivation in acute COVID-19 patients. Viruses. 2022;14. https://doi.org/10.3390/v14091872 .</Citation></Reference><Reference><Citation>Chen T, Song J, Liu H, Zheng H, Chen C. Positive Epstein-Barr virus detection in coronavirus disease 2019 (COVID-19) patients. Sci Rep. 2021;11:10902.</Citation><ArticleIdList><ArticleId IdType="pubmed">34035353</ArticleId><ArticleId IdType="pmc">8149409</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-90351-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Frozza FTB, Fazolo T, de Souza PO, Lima K, da Fontoura JC, Borba TS, Polese-Bonatto M, Kern LB, Stein RT, Pawelec G, Bonorino C. A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production. Med Microbiol Immunol. 2023;212:75&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">36512097</ArticleId><ArticleId IdType="doi">10.1007/s00430-022-00758-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Hollmann C, Kalanidhi S, Grothey A, Keating S, Mena-Palomo I, Lamer S, Schlosser A, Kaiping A, Scheller C, Sotzny F, Horn A, Nurnberger C, Cejka V, Afshar B, Bahmer T, Schreiber S, Vehreschild JJ, Miljukov O, Schafer C, Kretzler L, Keil T, Reese JP, Eichner FA, Schmidbauer L, Heuschmann PU, Stork S, Morbach C, Riemekasten G, Beyersdorf N, Scheibenbogen C, Naviaux RK, Williams M, Ariza ME, Prusty BK. Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and Long COVID. medRxiv. 2023. https://doi.org/10.1101/2023.06.23.23291827 .</Citation></Reference><Reference><Citation>Kiss T, Tarantini S, Csipo T, Balasubramanian P, Nyul-Toth A, Yabluchanskiy A, Wren JD, Garman L, Huffman DM, Csiszar A, Ungvari Z. Circulating anti-geronic factors from heterochonic parabionts promote vascular rejuvenation in aged mice: transcriptional footprint of mitochondrial protection, attenuation of oxidative stress, and rescue of endothelial function by young blood. Geroscience. 2020;42:727&#x2013;48.</Citation><ArticleIdList><ArticleId IdType="pubmed">32172434</ArticleId><ArticleId IdType="pmc">7205954</ArticleId><ArticleId IdType="doi">10.1007/s11357-020-00180-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiss T, Nyul-Toth A, Balasubramanian P, Tarantini S, Ahire C, Yabluchanskiy A, Csipo T, Farkas E, Wren JD, Garman L, Csiszar A and Ungvari Z. Nicotinamide mononucleotide (NMN) supplementation promotes neurovascular rejuvenation in aged mice: transcriptional footprint of SIRT1 activation, mitochondrial protection, anti-inflammatory, and anti-apoptotic effects. Geroscience. 2020. https://doi.org/10.1007/s11357-020-00165-5 .</Citation></Reference><Reference><Citation>Tarantini S, Valcarcel-Ares MN, Toth P, Yabluchanskiy A, Tucsek Z, Kiss T, Hertelendy P, Kinter M, Ballabh P, Sule Z, Farkas E, Baur JA, Sinclair DA, Csiszar A, Ungvari Z. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox Biol. 2019;24:101192.</Citation><ArticleIdList><ArticleId IdType="pubmed">31015147</ArticleId><ArticleId IdType="pmc">6477631</ArticleId><ArticleId IdType="doi">10.1016/j.redox.2019.101192</ArticleId></ArticleIdList></Reference><Reference><Citation>Csiszar A, Yabluchanskiy A, Ungvari A, Ungvari Z, Tarantini S. Overexpression of catalase targeted to mitochondria improves neurovascular coupling responses in aged mice. Geroscience. 2019;41:609&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">31643012</ArticleId><ArticleId IdType="pmc">6885076</ArticleId><ArticleId IdType="doi">10.1007/s11357-019-00111-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarantini S, Valcarcel-Ares NM, Yabluchanskiy A, Fulop GA, Hertelendy P, Gautam T, Farkas E, Perz A, Rabinovitch PS, Sonntag WE, Csiszar A, Ungvari Z. Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice. Aging Cell. 2018;17. https://doi.org/10.1111/acel.12731 .</Citation></Reference><Reference><Citation>Saleh J, Peyssonnaux C, Singh KK, Edeas M. Mitochondria and microbiota dysfunction in COVID-19 pathogenesis. Mitochondrion. 2020;54:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">32574708</ArticleId><ArticleId IdType="pmc">7837003</ArticleId><ArticleId IdType="doi">10.1016/j.mito.2020.06.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Georgieva E, Ananiev J, Yovchev Y, Arabadzhiev G, Abrashev H, Abrasheva D, Atanasov V, Kostandieva R, Mitev M, Petkova-Parlapanska K, Karamalakova Y, Koleva-Korkelia I, Tsoneva V, Nikolova G. COVID-19 complications: oxidative stress, inflammation, and mitochondrial and endothelial dysfunction. Int J Mol Sci. 2023;24. https://doi.org/10.3390/ijms241914876 .</Citation></Reference><Reference><Citation>Lin MM, Liu N, Qin ZH, Wang Y. Mitochondrial-derived damage-associated molecular patterns amplify neuroinflammation in neurodegenerative diseases. Acta Pharmacol Sin. 2022;43:2439&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pubmed">35233090</ArticleId><ArticleId IdType="pmc">9525705</ArticleId><ArticleId IdType="doi">10.1038/s41401-022-00879-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantle D, Hargreaves IP, Domingo JC, Castro-Marrero J. Mitochondrial dysfunction and coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview. Int J Mol Sci. 2024;25. https://doi.org/10.3390/ijms25010574 .</Citation></Reference><Reference><Citation>Kow CS, Ramachandram DS, Hasan SS. Coenzyme Q10 therapy in patients with post COVID-19 condition. Lancet Reg Health Eur. 2023;25:100567.</Citation><ArticleIdList><ArticleId IdType="pubmed">36691396</ArticleId><ArticleId IdType="pmc">9850420</ArticleId><ArticleId IdType="doi">10.1016/j.lanepe.2022.100567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansen KS, Mogensen TH, Agergaard J, Schiottz-Christensen B, Ostergaard L, Vibholm LK, Leth S. High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur. 2023;24:100539.</Citation><ArticleIdList><ArticleId IdType="pubmed">36337437</ArticleId><ArticleId IdType="doi">10.1016/j.lanepe.2022.100539</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>